Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease

ClinicalTrials.gov ID: NCT04939116

Public ClinicalTrials.gov record NCT04939116. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 6:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of Safety and Efficacy of ANG-3070 in Patients With Primary Glomerular Disease and Persistent Proteinuria

Study identification

NCT ID: NCT04939116
Recruitment status: Not listed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Angion Biomedica Corp; Industry
Enrollment: 100 participants

Conditions and interventions

Conditions

Interventions

ANG-3070 Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 23, 2021
Primary completion: Jul 30, 2023
Completion: Aug 30, 2023
Last update posted: Mar 22, 2022

2021 – 2023

United States locations

U.S. sites: 18
U.S. states: 13
U.S. cities: 16

Facility	City	State	ZIP	Site status
University of Alabama at Birmingham	Birmingham	Alabama	35294	Not yet recruiting
Amicis Reserach Center	Northridge	California	91324	Recruiting
Amicis Reserach Center	Vacaville	California	95687	Recruiting
South Florida Research Institute	Lauderdale Lakes	Florida	33313	Recruiting
Genesis Clinical Research LLC	Tampa	Florida	33603	Recruiting
Davita Clinical Research	Columbus	Georgia	31904	Recruiting
The Johns Hopkins Hospital	Baltimore	Maryland	21287	Not yet recruiting
Massachusetts General Hospital	Boston	Massachusetts	02108	Not yet recruiting
Beth Israel Deaconess Medical Center	Boston	Massachusetts	02215	Not yet recruiting
Davita Clinical Research	Edina	Minnesota	55435	Recruiting
Clinical Research Consultants, LLC.	Kansas City	Missouri	64111	Recruiting
Frenova Renal Research/Nephrology and Hypertension Specialists	St Louis	Missouri	63017	Recruiting
St. Louis Kidney Care	St Louis	Missouri	63136	Recruiting
New Jersey Kidney Care	Jersey City	New Jersey	07305	Recruiting
NYU Langone Nephrology Associates	Mineola	New York	11501	Not yet recruiting
University of Pennsylvania	Philadelphia	Pennsylvania	19104	Not yet recruiting
Prolato Clinical Research Center	Houston	Texas	77054	Not yet recruiting
University of Vermont Medical Center	Burlington	Vermont	05401	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 11 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT04939116, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Mar 22, 2022 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04939116 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →